Apellis Pharmaceuticals Inc. logo

Apellis Pharmaceuticals Inc. (APLS)

Delisted
15 May 2026
NASDAQ (NGS) NASDAQ (NGS)
$
41. 03
0
0%
$
5.25B Market Cap
- P/E Ratio
- Div Yield
28.64M Volume
-4.51 Eps
$ 41.03
Previous Close
Day Range
41.03 41.05
Year Range
16.61 41.14
Want to track APLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Apellis Pharmaceuticals Inc. logo
APLS Apellis Pharmaceuticals Inc.
30 Apr 2026
-
-
Apellis Pharmaceuticals Inc. logo
APLS Apellis Pharmaceuticals Inc.
24 Feb 2026
-
-
Apellis Pharmaceuticals Inc. logo
APLS Apellis Pharmaceuticals Inc.
10 Nov 2025
1.6
1.67
Apellis Pharmaceuticals Inc. logo
APLS Apellis Pharmaceuticals Inc.
11 Aug 2025
-
-
Apellis Pharmaceuticals Inc. logo
APLS Apellis Pharmaceuticals Inc.
5 May 2025
-
-
Apellis Pharmaceuticals Inc. logo
APLS Apellis Pharmaceuticals Inc.
25 Feb 2025
-
-
Apellis Pharmaceuticals Inc. logo
APLS Apellis Pharmaceuticals Inc.
30 Oct 2024
-
-
Apellis Pharmaceuticals Inc. logo
APLS Apellis Pharmaceuticals Inc.
29 Jul 2024
-
-
Apellis Pharmaceuticals Inc. logo
APLS Apellis Pharmaceuticals Inc.
2 May 2024
-
-
Apellis Pharmaceuticals Inc. logo
APLS Apellis Pharmaceuticals Inc.
19 Feb 2024
-
-
Apellis Pharmaceuticals Inc. logo
APLS Apellis Pharmaceuticals Inc.
1 Nov 2023
-
-